Blood vessel replacements (vascular grafts) are used today for hemodialysis blood access, trauma repair and cardiovascular reconstruction. The first synthetic vascular grafts (blood vessel ...

New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

Cardiovascular diseases remain the leading cause of global mortality, necessitating robust screening programs. Multidisciplinary care teams reduce mortality rates in complex heart failure patients ...

Blood vessel replacements (vascular grafts) are used today for hemodialysis blood access, trauma repair and cardiovascular reconstruction The first synthetic vascular grafts (blood vessel replacements ...

Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of ...

A Korea Institute of Science and Technology (KIST) research team has developed a novel stent surface treatment technology using laser patterning. This technology promotes endothelial cell growth while ...

In a study published in the journal Burns & Trauma, researchers from Shanghai Jiao Tong University and Donghua University developed a new type of vascular graft using 3D printing and electrospinning.

NEW YORK (Reuters) - U.S. pharmaceutical and medical equipment maker Johnson & Johnson said on Monday it agreed to sell its Cordis vascular technology unit to Cardinal Health for $1.9 billion, ...

Johnson & Johnson will spend $16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division.The health care giant said Tuesday that it will pay $380 for each ...

Cardiovascular disease affects 315 million people globally and is the world’s leading cause of death. For the past quarter-century, it has been standard practice for heart surgeons to treat this by ...

Researchers at Mass General Brigham Heart and Vascular Institute and collaborators have developed and validated a new genetic risk test that can estimate a person’s inherited risk for eight common ...